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Objectives: Beside having roles in energy homeostasis and endocrine modulation, adipose tissue (AT) is now considered a promising
source of mesenchymal stromal cells (adipose-derived stromal cells or ASCs) for regenerative medicine. Despite numerous studies on
cultured ASCs, native human ASCs are rarely investigated. Indeed, the phenotype of ASCs in their native state, their localization
within AT and comparison with bone marrow-derived mesenchymal stromal cells (BM-MSCs) has been poorly investigated.
Design: To address these issues, the stroma vascular fraction (SVF) of human AT was extracted and native cell subtypes were
isolated by immunoselection to study their clonogenic potential in culture. Immunohistology on samples of human AT in
combination with reconstruction of confocal sections were performed in order to localize ASCs.
Results: Compared with BM-MNCs, all native ASCs were found in the CD34
þ cell fraction of the AT-SVF. Native ASCs expressed
classical mesenchymal markers described for BM-MSCs. Interestingly, CD34 expression decreased during ASC cell culture and
was negatively correlated with cell proliferation rate. Immunohistological analysis revealed that native ASCs exhibited specific
morphological features with protrusions. They were found scattered in AT stroma and did not express in vivo pericytic markers
such as NG2, CD140b or alpha-smooth muscle actin, which appeared during the culture process. Finally, ASCs spontaneous
commitment to adipocytic lineage was enhanced in AT from obese humans.
Conclusions: The use of complementary methodological approaches to study native human ASCs revealed their
immunophenotype, their specific morphology, their location within AT and their stemness. Furthermore, our data strongly
suggest that human ASCs participate in adipogenesis during AT development.
International Journal of Obesity (2011) 35, 1141–1153; doi:10.1038/ijo.2010.269; published online 25 January 2011
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Introduction
Besides being involved in energy homeostasis, adipose tissue
(AT) is an endocrine organ capable of secreting a large variety
of regulatory proteins, including cytokines, chemokines
and hormone-like factors such as leptin, adiponectin and
resistin, referred to as adipokines.
1,2 Such proteins partici-
pate in many other functions such as inflammation,
immunity and reproduction.
3 Excessive AT development
is thought to be the result of both adipocyte hypertrophy
and apparent hyperplasia.
4–8 As adipocytes are terminally
differentiated cells, and, as such, are considered incapable
of division,
9,10 the apparent increase in adipocyte number
is thought to originate from adipogenesis (the proliferation/
differentiation of adipocyte progenitor cells named preadi-
pocytes). Thus, the expansion of adipose mass requires the
presence of adipocyte precursor cells located in the stroma
vascular fraction (SVF) of ATand the presence of which could
also contribute to AT normal cell turnover during adulthood
as recently suggested.
11
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www.nature.com/ijoThe search for the origin of adipocyte progenitors revealed
that AT hosts a population of multipotent progenitors called
adipose-derived stromal cells (ASCs).
12,13 These progenitors
can give rise to osteoblasts, chondrocytes and adipocytes.
12
They also participate in and/or support angiogenesis or
vascular repair in ischemic limbs
14–16 and have immuno-
modulatory properties both in vitro and in vivo.
17,18
A number of studies of the characterization of ASCs have
revealed disparate and inconsistent parameters. Recurrent
questions concern the nature of native ASCs, their tissue
location, and their comparison with bone marrow-derived
mesenchymal stromal cells (BM-MSCs). Reports, including
our own, strongly suggest that native ASCs belong to an
AT-SVF-derived CD34
þ cell population and are negative
for haematopoietic (CD14, CD45) and endothelial markers
(CD31).
14,16,19,20 However, other groups propose the
existence of two progenitor cell populations within AT: ASCs
derived from CD34
þ cells and AT-MSCs derived from CD34
 
cells.
18 Nevertheless, all reports agree with the classical
BM-MSC surface immunophenotype of cultured ASCs:
CD73
þ, CD90
þ, CD105
þ, CD45
  and CD14
 .
21–25 Another
debated question concerns the origin of native ASCs.
Indeed, although Crisan et al.
26 recently proposed that MSCs
originate from a pericyte population lacking CD34 expres-
sion, Traktuev et al.
27 suggested a CD34
þ pericyte origin for
ASCs. In this context, this study aimed to clarify and better
define the surface immunophenotype of both native and
cultured human ASCs as compared with BM-MSCs, to
evaluate in situ their morphology and to define their tissue
localization within intact human AT samples. We show
herein that native human ASCs (i) are CD34 positive (the
expression of which is dramatically decreased in vitro when
cells proliferate) (ii) display both stromal and perivascular
positions but (iii) do not express in situ pericyte markers such
as NG2 and CD140b, (iv) and exhibit in situ a peculiar cell
morphology with long protrusions. Furthermore we propose
that ASCs support AT growth, as their number is diminished
and the expression of adipogenic markers increase as obesity
and adipocyte hyperplasia progress.
Materials and methods
Adipose tissue sampling and SVF isolation
Human subcutaneous AT samples were obtained from
Caucasian women undergoing plastic surgery for lean
(body mass index (BMI)o25kgm
 2) and obese class I
(BMI 30–34.9kgm
 2) donors and undergoing bariatric
surgery for classes II–III (BMIX35kgm
 2) obese subjects.
The donors had a stable weight for at least 3 months before
fat collection and their mean age was 43.7±1.8 years,
44.4±1.7 years and 43.4±1.6 years for lean, class I and class
II–III patients, respectively (some clinical characteristics of
some class II–III obese donors are presented in Supplemen-
tary data 1). All research subjects provided their informed
written consent before their surgery allowing the use of
their tissue specimens for research purposes. The protocol
followed the Declaration of Helsinki guidelines and was
approved by the local ethics committee. The SVF and mature
adipocytes were isolated from subcutaneous AT by colla-
genase digestion as previously described.
17,28 As AT samples
were derived from various surgical interventions (liposuction or
dermolipectomy), ASC yield was compared depending on the
surgical procedure. No statistically significant differences were
found (1.3 10
e5±7.1 10
e4 vs 1.2 10
e5±7.3 10
e4 ASCs
per g of AT for liposuction and dermolipectomy, respectively).
Adipocyte diameter determination
Once isolated, mature adipocytes were suspended in
ECBM (Endothelial Cell Basal Medium, containing no
growth factors)/0.5% BSA (Bovine Serum Albumin)
(1V/10V) and 5ml of cell suspension were placed onto plastic
slides. Three distinct calibrated fields were taken to measure
manually adipocyte diameters with NIS software (Nikon,
Champigny-sur-Marne, France). Fat cell-like shapes were
labelled with the nucleus dye DAPI (40,6-diamidino-2-
phenylindole). Among them 94±1% were nucleated and
identified as adipocytes (85±7% and 99±1%, for small
(o60mm) and large (4100mm) adipocytes, respectively).
Adipose tissue CD34
þ cell sorting and culture
Human AT-derived CD34
þ and CD34
þ/CD31
  cells were
isolated from SVF using CD34 nanoparticles with MACS Cell
Separation Technology (Myltenyi Biotec SAS, Paris, France)
(CD34
þ cell fraction purity 81.5±2.5% and o0.5% for
positive and negative fractions, respectively) or StemCell
Technologies SARL (Grenoble, France) (CD34
þ cell fraction
purity 92.9±0.8%) according to the manufacturer’s instruc-
tions and as previously described.
16 Crude SVF cells or
magnetically sorted CD34
þ cells were initially plated at a
density of 4000 cellscm
 2 in a-MEM medium supplemented
with 2% or 10% fetal calf serum (FCS). After 24h at 371C and
5% CO2, non-adherent cells were removed by phosphate-
buffered saline (PBS) washing. The adherent fraction was
then cultured in vitro in the same culture medium, with
medium changed three times a week. After 8 days, ASC at
passage 0 were harvested with trypsin EDTA (Invitrogen
SARL, Cergy Pontoise, France). The number of viable cells
was determined using trypan blue exclusion. To study the
effect of cell passaging on immunophenotype, cells were
then plated at a density of 2000 cellscm
 2 and cultured for 6
additional days (passage 1). For kinetic cell growth and CD34
expression analysis, cells were plated at a density of 4000
cellscm
 2 in a-MEM medium supplemented with 2 or 10%
FCS, and harvested daily over an 8-day period. Cells were
then counted and immunophenotyped by flow cytometry.
Isolation and culture of human bone marrow-mononuclear cells
(BM-MNCs)
As, adhesion to plastic is the way to select MSCs from
BM-MNCs, BM of healthy donors was obtained from filters
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grafts. They gave their written informed consent. The
protocol followed the Declaration of Helsinki guidelines
and was approved by the local ethics committee. BM-MNCs
were obtained by density gradient (d¼1.077gcm
 3) centri-
fugation of total BM cells. BM-MNCs were plated at
100000–150000 cellscm
 2 in the same medium as AT
CD34
þ cells (a-MEM supplemented with 10% FCS). After
2 days, non-adherent cells were harvested, and adherent
cells were detached by use of trypsin/EDTA in order to study
their immunophenotype after culture and compare it with
the one of AT-SVF.
Clonogenic assay
CD34
þ and CD34
  cells from AT were plated at low density
(16 cellscm
 2). After 2 weeks, cells were rinsed with PBS,
fixed in methanol and stained with 6% Giemsa. Colonies
containing more than 50 colony-forming unit fibroblasts
(CFU-Fs) were counted. CFU-F frequency was calculated by
dividing the colony number by the number of seeded cells.
Two-day adherent and non-adherent BM-MNCs were seeded
at 1000 and 40000 cellscm
 2, respectively, for 11 days. Cells
were rinsed with PBS, fixed in methanol and stained with 6%
Giemsa. Colonies containing more than 50 CFU-Fs were
counted. CFU-F frequency was calculated by dividing the
colony number by the number of seeded cells.
Adipogenic differentiation
CD34
þ and CD34
  cells from AT were induced to undergo
adipogenic differentiation with a-MEM medium supplemen-
ted with 10% FCS, 1mmoll
 1 dexamethasone, 60mmoll
 1
indomethacine (adipogenic medium) and 450mmoll
 1 iso-
butylmethylxanthine for 3 days. After 3 days, medium was
replaced by adipogenic medium. After 20 days, cultures were
rinsed with PBS, fixed with 10% formaldehyde; lipid droplets
were stained with Oil-red O solution.
Osteogenic differentiation
CD34
þ and CD34
  cells from AT were plated at 4000
cellscm
 2 in osteogenic induction medium (a-MEM
supplemented with 10% FCS, 0.1mmoll
 1 dexamethasone,
50mmoll
 1 ascorbic acid and 3mmoll
 1 sodium phosphate
monobasic) for 2 weeks. Sodium phosphate monobasic was
then replaced with b-glycerophosphate (10mmoll
 1), and
cells were cultured for 1 week. Cultures were rinsed with PBS,
fixed with 10% formaldehyde, and stained with alizarin red
for visualizing matrix mineralization.
Flow cytometry
At least 1.10
5 cells (AT-CD34
þ, ASCs or BM-MNCs) in
PBS/0.5% BSA and sodium azide (1/1000 w/v) were stained
with various combinations of saturating amounts of mono-
clonal antibodies conjugated with fluorescein isothiocyanate
(FITC), phycoerythrin (PE) or PE-cyanin 5 (PC5) (Supple-
mentary data 2) and their respective isotype controls
(41C, 30min, dark). The labelled cells were analyzed by
multiparameter flow cytometry (EPICS XL flow cytometer,
Beckman-Coulter, or FACScanto cytometer, BD Biosciences,
Le Pont de Claix, France) and FlowJo (Ashland, OR, USA)
(Tree Star) or FCS express software (DeNovo Software, Los
Angeles, CA, USA).
Immunohistochemistry and immunocytochemistry and confocal
microscopy
Intact human subcutaneous AT pieces (2–3mm
3) were
fixed in neutral buffered 4% (w/v) paraformaldehyde (1h,
room temperature (RT)), blocked in PBS/3% BSA (30min,
RT), and incubated in PBS/0.1% BSA/0.2% triton/0.05%
tween (IF buffer) with primary antibodies overnight at 41C
(Supplementary data 3). After washing steps in IF buffer, AT
samples were incubated for 1h with secondary antibodies or
with an antibody against lectin (Supplementary data 3).
Nuclei were stained with Hoescht 33258 or TO-PRO-3
(Invitrogen SARL) (for confocal microscopy). Fluorescence
analysis was performed utilizing a Nikon (Paris, France),
inverted Eclipse TE300 microscope (20  and 40  objec-
tives) or a LSM510 Confocal Laser Scanning microscope
equipped with an Axiovert 200M inverted microscope (Carl
Zeiss, Jena, Germany). For confocal microscopy analysis, AT
samples were visualized with an 63X objective lens (Plan-
Apochromat, N.A. 1,4, Oil) and excited using three laser lines
(488, 543 and 633nm), and the emission was collected
through appropriate narrow band-pass filters. Image stacks
(25-mm thickness) were collected at 0.46-mm intervals along
the optical axis. Each image was produced from an average of
60 Z-overlapping stacks using Zeiss LSM software (Carl Zeiss
S.A.S., Le Pecq, France), and was processed to produce a
surface-rendered three-dimensional model.
Human native CD34
þ cells from AT were cytocentrifuged,
placed onto glass slides, fixed in cold acetone ( 201C,
20min) and washed with Tris-buffered saline (TBS) for
immunocytochemistry. Antigen demasking was realized in
citrate buffer (30min, 971C). Human CD34
þ cells from AT
were cultured in LabTek (BD Biosciences) chamber slides for
1 week and fixed in 4% paraformaldehyde (1h, RT). After
washing steps (TBS), permeabilization (TBS/0.1% Triton) and
blocking, cells were incubated with anti-aSMA or anti-NG2
primary antibodies (Supplementary data 3) (1h or overnight,
respectively). Cells were incubated with corresponding
secondary antibody (30min, RT) after washing. Nuclei were
stained with DAPI (40,6-diamino-2-phenylindole dihy-
drochloride).
RNA isolation and real-time PCR
Total RNA was extracted from AT CD34
þ/CD31
  cells by
use of the Rneasy kit (QIAGEN S.A, Courtaboeuf, France),
and RNA concentrations were determined by fluori-
metric assay (Ribogreen, Invitrogen). RNA (0.5mg) was
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(Random Hexamers and dNTPs were from Invitrogen). Room
temperature was also carried out without the superscript
enzyme on RNA samples. Primers for lipoprotein lipase
(LPL), Glycerol 3-phosphate dehydrogenase (GPDH),
Nanog, Oct-4 and hTERT were provided by Applied
Biosystems (Assays on demand, Courtaboeuf, France). Runx2
and osteocalcin primers were designed by use of Primer
Express v2.0 (Applied Biosystems) (Supplementary data 4).
The amplification reaction was carried out with 15ng
complementary DNA samples in 96-well plates (Applied
Biosystems) in a GeneAmp 7500 sequence detection
system. The PCR mixture contained 5ml of Taqman primers
(5X prediluted in water) or 300nmoll
 1 for Runx2 or
Osteocalcin and 10mlo f2   Taqman PCR master Mix
or 10mlo f2   SyberGreen PCR Master Mix (Applied
Biosystems). All reactions were performed at 501C (2min),
951C (10min), then 40 cycles of 951C (15s) and 601C
(1min). The results were analyzed by use of GeneAmp 7500,
and all values were normalized to that of 18S rRNA.
Statistical analysis
Statistical analysis involved use of GraphPad (San Diego, CA,
USA) and Statistica (Statsoft, Tulsa, OK, USA). Values are
mean±standard error of the mean of (n) separate experi-
ments. Comparisons among different groups were analyzed
by ANOVA, then post-hoc Dunnet multiple comparison tests
or Mann–Whitney test for two groups. Differences were
considered statistically significant at Po0.05.
Results
Phenotypic changes of cells from human adipose tissue SVF and
BM-MNCs during the adhesion phase of primary culture
Flow cytometry analysis of freshly harvested human AT SVF
stained with anti-CD45 and anti-CD34 antibodies confirmed
that native human SVF is a heterogeneous fraction made
up of several cell populations, as was expected and in
accordance with previous work, including our own
10,13,16
(Figure 1a). The cell populations in SVF included about 30%
leukocytes, characterized as CD45
þ cells, and a cell popula-
tion defined as CD34
þ/CD45
 , which represented about
40% of the cells from the SVF. Because adhesion to plastic is
the most frequent way to select both ASCs and BM-MSCs, we
used flow cytometry to investigate the evolution of CD34
and CD45 marker expression, together with that of standard
MSC markers (CD73, CD13) in human SVF cells or BM-MNCs
before and 2 days after adhesion to plastic. For the SVF, the
adhesion phase was associated with an increased proportion
of cells expressing CD13 and CD73 classic markers to
identify BM-MSCs and a decreased proportion of cells
positive for the leukocyte marker CD45 (Figure 1b), with
a concomitant increase in proportion of cells expressing
CD34 (80%). Freshly harvested BM-MNCs contained less
than 5% of CD34
þ cells, and in contrast to cells from the
CD45
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Figure 1 Phenotypic characterization by flow cytometry of native and short-
term cultured AT-SVF and BM-MNCs. (a) Representative dot blot of flow-
cytometry analysis of freshly harvested AT-SVF stained with CD45 Fluorescein
IsoThioCyanate (FITC) and CD34 Phycoerythrin (PE) antibodies. (b and c)
Immunophenotype of AT-SVF cells (b) and BM-MNCs (c) in their native
state (black bars) or after 2 days of culture (white bars) using CD45 (FITC),
CD13 (FITC), CD73 (PE) and CD34 Phycoerythrin-Cyanin 5.1 (PC5) cell
surface markers. Results are percentage of positive cells and are expressed as
means±s.e.m. for 27–30 separate experiments. *Po0.05, **Po0.01,
***Po0.001.
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activity (Supplementary data 5) showed no CD34
þ cells
2 days after adhesion to plastic (Figure 1c).
CD34 expression is downregulated during cell culture and is
negatively correlated with cell expansion
Because of conflicting results for CD34 expression in native
ASCs, we hypothesized that changes in CD34 expression
could be related to cell culture. Freshly harvested human
AT-CD34
þ cells were cultured in 2 or 10% FCS for 8 days,
and CD34 expression was analyzed using flow cytometry.
In parallel, the expression of standard MSCs and haemato-
poietic markers was studied before and after 8 days of
culture. As expected, cell yield was greater than fivefold
higher in 10 than 2% FCS medium (Figure 2a). Whatever
the medium used (2 or 10% FCS) and in agreement with
our previous observation, the proportion of CD34
þ cells
increased during the first 3 days of culture (Figure 2b).
Then, as cell number began to increase, the proportion of
CD34
þ cells began to decrease in 10% FCS medium. In
contrast, the proportion of CD34
þ cells remained relatively
stable when cell proliferation was low, that is, in 2% FCS
medium (about 70% of the cells grown in 2% FCS medium
expressed CD34 after 8 days of culture) (Figure 2b).
Additionally, CD34 mean fluorescence intensity expressed
by AT CD34
þ cells was calculated during the culture of
AT CD34
þ cells in 2 or 10% FCS. As presented in Figures 2c
and d, together with the decrease in the percentage
of CD34
þ cells there was a dramatic decrease in CD34
fluorescence intensity when AT-CD34
þ cells were cultured
in 10% FCS. Moreover, a negative correlation between cell
expansion and expression of CD34 marker was found
(Figure 2e). Furthermore, in freshly harvested SVF cells, the
relative amount of CD34 mRNA normalized to that of
ubiquitin was 103.2±8.3 (arbitrary units), whereas cell
expansion led to a 80-fold decrease in CD34 mRNA level
(1.3±1.0 arbitrary units) (data not shown). Collectively,
these data suggest that both the quantity of CD34
þ cells
and the expression of CD34 protein are diminished when
AT-CD34
þ cells are expanded in culture. To note and as
expected the proportion of AT CD34
þ cells expressing classic
BM-MSC markers such as CD13, CD29, CD73 and CD90 was
increased after 8 days of culture whatever the medium used
(Figure 2f).
Native human adipose tissue-derived CD34
þ cells contain
CFU-F activity, adipogenic and osteogenic potentials
CFU-F activity was assessed in freshly harvested CD34
þ and
CD34
  cell populations from AT. CFU-F activity was
restricted to the CD34
þ cell population (Figures 3a and b).
After inducing adipogenic differentiation in confluent
cells, we detected lipid accumulation by Oil-red O staining
and triglyceride content (data not shown) in the CD34
þ
cell fraction (Figures 3c and d). At 3 weeks after the
induction of osteogenic differentiation, matrix mineraliza-
tion was observed in the CD34
þ cell fraction (Figures 3e and
f). Under the same conditions, the CD34
  cell fraction
from AT revealed neither osteogenesis nor adipogenesis
(Figures 3c–f).
Phenotypic characterization of native and cultured ASCs
According to the results shown above, we assumed that
native ASCs were in the CD34
þCD45
  cell fraction of the AT
derived-SVF. We studied the expression of various membrane
markers in the freshly harvested cell population before
culture and after 8 days of culture. Cell culture led to a clear
phenotype homogenization (Table 1 and Supplementary
data 6 and 7), with no marked phenotype evolution between
the first and second cell passage (data not shown). More than
95% of cultured ASCs expressed a large variety of MSCs
markers (CD9, CD10, CD13, CD49e, CD73, CD90 and
CD166) but no haematopoietic markers (CD3, CD11c,
CD14, CD15, CD16, CD18 and CD41) (Table 1).
In situ localization of native ASCs
To examine the spatial organization of ASCs within human
AT, we investigated the vascular network in intact human AT
by anti-lectin or -CD31 antibody staining, which produced
identical patterns (data not shown). Native ASCs were
localized with anti-CD34 antibodies and were distinguished
from leukocytes and endothelial cells with the use of anti-
CD45 and anti-lectin antibodies, respectively. Adipocytes
were detected by phase contrast imaging. We found human
AT capillaries, characterized by aligned cells positive for
lectin or CD34, distributed among adipocytes (Figure 4a).
Interestingly, CD34 staining revealed CD34
þ cells mainly
located in AT stroma and sometimes near capillaries
(Figure 4a). To discriminate ASCs from AT capillary endothe-
lial cells, double staining with anti-lectin and -CD34
antibodies was performed (Figure 4b). A large proportion of
ASCs were visualized as scattered throughout AT stroma,
some were found close to capillaries and seldom adhering
to AT capillaries (Figures 4a and b). To verify that ACS
stromal location was indeed devoid of capillaries and
because of AT intrinsic structure, that is the presence of
large mature adipocytes sometimes reaching diameters of
100–150mm, reconstruction of confocal sections on 25-mm
thickness from human AT sample was performed. Human AT
was labelled with anti lectin and CD34. The optical
sectioning capability of confocal imaging confirmed that
human native ASCs located in the stroma of AT were
not close to capillaries. Moreover, in their native micro-
environment human ASCs exhibited a branched morpho-
logy with several lateral protrusions, which could reach a
length of 80mm (Figure 4c and Supplementary data movie).
Furthermore, some cell branches, already revealed in
Figures 4a and b, could form a network completely
surrounding mature adipocytes (Figure 4c and Supplemen-
tary data movie).
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native ASCs
To better characterize native ASCs, we analyzed the expres-
sion of the pericyte markers NG2 and CD140b in intact
human AT. Double staining of AT samples with anti-CD31
and -NG2 or -CD140b antibodies revealed positive staining
for perivascular NG2 (Figure 5a) and CD140b (Figure 5d)
on AT capillaries (CD31
þ network). Further CD34 staining
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Figure 2 Phenotype of native and cultured AT-derived CD34
þ cells. AT-derived CD34
þ cells were plated in a-MEM supplemented with 2% or 10% FCS and
harvested every day for 8 days. (a) The number of harvested cells was counted everyday. Data are mean±s.e.m. of harvested cells per cm
2 from four to six
independent experiments. *Po0.05, 2 versus 10% FCS. Native immunoselected CD34
þ cells following 8 days of culture with either 2 or 10% SVF were analysed by
flow cytometry for the expression of CD34. The percentage of adherent cells expressing CD34 antigen is presented in panel b. Data are expressed as mean±s.e.m.
of four to six independant experiments. *Po0.05, 2 versus 10% FCS. (c) Representative histograms showing the mean fluorescence intensity for CD34 marker by
native immunoselected CD34
þ cells after 2, 5 or 8 days of culture with 2% (red line) or 10% FCS (black line). (d) Quantitative analysis of CD34 mean fluorescence
intensity after 2, 5 or 8 days of culture with 2% (white histograms) or 10% FCS (black histograms). Data are presented as mean mean±s.e.m. of four independant
experiments. *Po0.05, day 0 versus day 8. (e) The proportion of CD34
þ cells was evaluated by flow cytometry, and number of harvested cells per cm
2 was counted.
Results are expressed as percentage CD34
þ cells after 1 week of culture versus the fold expansion at day 8 (number of harvested cells divided by the number of
seeded cells at day 0). (f) Isolated AT-CD34
þ cells were analysed by flow cytometry with CD34 (PC5), CD45 (FITC), CD13 (PE), CD29 (FITC), CD73 (PE) and CD90
(FITC) antibodies, before (black bars) and after culture (8 days) in a-MEM supplemented with 2% (white bars) or 10% FCS (grey bars). Data are mean±s.e.m.
percentage of positive-stained cells from 3–16 separate experiments. **Po0.01 and ***Po0.001, native versus 8-day-cultured cells.
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þ and CD140b
þ cells revealed these cells in the
perivascular location in intact human AT, but cells were
not CD34
þ (Figures 5b, c, e and f for NG2 and CD140b,
respectively). Further flow cytometry analysis of NG2
and CD140b expression in cells freshly isolated from the
SVF with anti-CD34, -CD31, -CD140b and -NG2 anti-
bodies revealed few cells expressing pericyte markers:
1.8±0.4% and 12.7±3.5% of the total cells were positive
for NG2 and CD140b, respectively, and o 2% of these were
CD34
þ (data not shown). Additionally, flow cytometry
results of in vitro experiments to study the effect of culture
on the expression of pericyte markers NG2, CD140b and
a-SMA by CD34
þ cells revealed the expression of NG2
and CD140b increased by the culture process (3.5- and
5-fold increase, respectively, Figure 5g). The increase in
NG2 and a-SMA expression by ASCs during cell culture
was confirmed using immunocytochemistry (Figures 5h
and i).
Native ASC microenvironment changes modify both the content
of ASCs in subcutaneous AT and the expression of adipocyte
lineage genes by native ASCs
First, the gene expression of transcription factors charac-
teristic of embryonic/pluripotent stem cells genes such as
Nanog and Oct-4 were analyzed in human native ASCs and
compared with human embryonic stem cells (ESCs). Native
ASCs showed expression of Oct-4 and Nanog (30.5±19.2 and
2.2±1, respectively; 2.5- to 3-fold less expressed than in
ESCs, Po0.05, n¼3, data not shown) but not hTERT. Second,
the impact of tissue microenvironment changes on the
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Figure 3 CFU-F activity and adipogenic and osteogenic differentiation of AT-derived CD34
þ and CD34
  cells. CFU-F) assay of AT-CD34
þ and -CD34
  cells.
(a) Images of a representative experiment and (b) percentage of CFU-Fs in the CD34
þ and CD34
  fractions of the SVF (n¼6, *Po0.001). AT-derived CD34
þ and
CD34
  cells were cultured under adipogenic conditions for 3 weeks; Oil-red O staining for lipid accumulation (c) and quantification (d)( n¼6, *Po0.001).
AT-derived CD34
þ and CD34
  cells were cultured under osteogenic conditions for 3 weeks; alizarin-red staining for matrix mineralization (e) and quantification
(f)( n¼6, *Po0.001).
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of ASCs by flow-cytometry analyses was examined and
the expression of several genes involved in adipogenic and
osteogenic programs in freshly harvested ASCs from donors
exhibiting class I to class III obesity by real-time PCR analyses
was investigated. Subcutaneous AT from class I obese
individuals exhibited more ASCs than lean individuals
(1.1 10
e5±8.7 10
e3 vs 1.6 10
e5±1.4 10
e4 ASCs per g
of AT in lean vs class I obese donors, respectively, Po0.05,
n¼50 and 38, respectively) and class II–III obese individuals
(1.5-fold decrease, n¼59, Po0.05, Figure 6a). The lower
number of ASCs in class II–III obese subjects was accom-
panied by a reduced mean diameter of subcutaneous mature
adipocytes (Figure 6b), but with higher transcript levels of
mRNA encoding for the adipocyte markers LPL and GPDH as
compared with subjects with class I obesity (Figures 6c and
d). To note, no expression of osteogenic genes such as Runx2
and osteocalcin were detected in native ASCs and no change
in their expression was found whatever the degree of obesity
(data not shown).
Discussion
In this study, we show that native ASCs are contained in the
CD34
þ cell population of AT and that the expression of
CD34 marker is negatively correlated with cell expansion
in vitro. In intact human AT, ASCs were found scattered in
AT stroma, occasionally close to capillaries but interestingly
without expressing pericytic markers in situ, as previously
reported. Excessive AT development, as seen in humans with
severe obesity (class II–III), was associated with a lower ASC
number and smaller mean adipocyte diameter together with
a marked increase in the expression of adipogenic molecular
markers (LPL and GPDH) in native ASCs from subcutaneous
AT suggesting activation of an adipogenic differentiation
program presumably to support the adipocyte hyperplasia
seen in severe forms of obesity.
CD34 belongs to the family of single-pass transmembrane
sialomucin proteins that contains three members: CD34,
podocalyxin and endoglycan.
29 For 25 years, CD34 has
been widely used to identify and isolate haematopoietic stem
and progenitor cells.
30 More recently, CD34 has been used
to help identify other tissue-specific stem or progenitor
cells such as satellite muscle cells and epidermal precur-
sors.
29 It is also widely used as a marker of vascular
endothelial cells,
31–33 endothelial progenitor cells,
34 fibro-
cytes,
35 human decidual stromal cells,
36 satellite cells
37 and
keratocytes.
38 Culture-expanded BM-MSCs are generally
considered negative for CD34 marker, but the expression of
CD34 in freshly harvested MSCs is still debated. Indeed,
Table 1 Phenotypic characterization of native and cultured ASCs
Native ASCs Cultured ASCs
Mesenchymal markers
CD9 51±0.2 97.4±1.5
CD10 63.6±3.4 98.9±0.3
CD13 81.9±3.4 99.7±0.04
CD49e 80.3±3.7 100±0.05
CD55 42.1±6.9 99.7±0.06
CD73 70±4.01 98.4±0.4
CD90 73.7±4.9 99.6±0.2
CD166 0.2±0.05 97.3±0.7
Haematopoietic markers
CD3 0.2±0.2 0.3±0.1
CD11c 0±00 . 4 ±0.06
CD14 0.2±0.2 0.6±0.1
CD15 0.6±0.2 1.5±0.6
CD16 0.4±0.2 0.1±0.1
CD18 0.3±0.2 0.5±0.2
CD41 0.9±0.3 1.7±0.8
Abbreviation: ASCs, adipose-derived stromal cells. Data are expressed as mean
percentage±s.e.m.
CD34 Lectin/CD34
Lectin/CD34
ab
c
Figure 4 In situ ASC localization. Human subcutaneous AT samples were
stained with anti-CD34 (green), and adipocytes were visualized by phase
contrast imaging (a)( 2 0   magnification). (b) Capillaries were stained with
anti-lectin (green), and ASCs were localized with use of anti-CD34 antibody
(red). Nuclei were stained with Hoescht 33258 (blue) (40  magnification).
Representative microscopy results from at least 10 independent experiments
(bar, 50mm) (c) Representative 3D-stack projection of human AT. Capillaries
were stained with anti-lectin (green), and ASCs were localized with use of
anti-CD34 antibody (red). Nuclei were stained with TO-PRO 3 Iodide (blue)
(63  magnification). Representative microscopy results from at least five
independent experiments (bar, 10mm).
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Figure 5 Pericyte marker expression in AT. Human subcutaneous AT samples were stained with anti-NG2 (green) and anti-CD31 (red) (a) or anti-CD34 (red)
antibodies (b, c); with anti-CD31 (green) and -CD140b (red) antibodies (d); or anti-CD34 (red) and -CD140b (green) antibodies (e, f). Representative microscopy
results from five independent experiments (bar, 25mm). (g) Flow cytometry analysis of pericyte markers CD140b and NG2 expression in native (black bars) and
cultured (grey bars) AT-SVF. Data are mean±s.e.m. percentage of positive cells from three separate experiments. *Po0.05 native vs cultured SVF cells. (h) CD34
þ
cells were centrifuged on cytospin slides before culture or after culture on Labtek chamber slides for 1 week (i). Slides were double-labelled with anti-NG2 (green)
and a smooth muscle actin (red) antibodies. Nuclei were stained with DAPI (blue).
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CD34
  fraction, which led the International Society for
Cell Therapy to formulate a position statement indicating
that MSCs are CD34
 .
39 A limited number of studies have
reported human CD34
þ BM-derived cells that give rise to
fibroblast-like stromal elements bearing osteogenic and
chondrogenic differentiation potentials.
40–42 In this paper
we show that the adherent fraction of BM-MNCs did
not contain CD34
þ cells (although was highly enriched in
CFU-F activity).
The expression of CD34 in human ASCs is still debated. In
this study, we show that only CD34
þ cells from human AT
(and not CD34
  cells) were able to show fibroblast-forming
activity, as well as lipid-droplet formation or matrix miner-
alization under adipogenic or osteogenic culture conditions.
Our data are in agreement with our previous results
14,16,19
and those of other groups that studied these cells before
culture.
20,24,43,44 Moreover, we showed that CD34 expression
negatively correlated with ASCs expansion. In haematopoie-
tic stem or progenitor cells, CD34 membrane expression is
known to be downregulated as haematopoiesis progresses.
30
Such downregulation seems to be a consistent feature of
other stromal cells, such as stromal-derived keratocytes,
initially isolated as CD34
þ cells, which lose their CD34
expression during in vitro expansion.
38 In this work we
demonstrate that in their native state and in contrast to
human BM-MSCs, human ASCs are contained in the CD34
þ
cell fraction. Whether the downregulation of CD34 expres-
sion is an in vitro consequence or the result of a more
committed phenotype as compared with what occurs with
the differentiation of haematopoietic stem cells remains
undefined.
Conventional techniques used to visualize tissue structure
generally involve excision and sectioning of the tissue;
however, such techniques do not facilitate direct visualiza-
tion of the complex cellular interactions taking place in 3-D.
Hence, to better characterize native ASCs, we used immu-
nohistochemistry of intact human AT analyzed by fluores-
cent microscopy and also confocal microscopy. This method
preserves the 3-D structure and allowed us to finely
investigate ASC distribution within the complex 3-D archi-
tecture of human AT (thickness of 25mm). We found human
ASCs to exhibit specific morphological features with very
long protrusions allowing them to form networks surround-
ing mature adipocytes. Native human ASCs were found
scattered within AT. Indeed, human ASCs were largely
located in the stroma of human subcutaneous AT, although
some were found near the capillary network. However, they
rarely exhibited a pericytic position. Interestingly, similar
results were found in mouse subcutaneous AT, with mouse
ASCs found in the deep layers of AT as well as near
microvessels.
45 The findings are not consistent with earlier
studies showing that MSCs from multiple organs, including
AT, have a perivascular origin and exhibit pericyte fea-
tures.
26,27 Traktuev et al.
27 proposed that ASCs are pericytes
because culture-expanded ASCs were positive for CD140b
and NG2 pericyte markers, and CD140b
þ and NG2
þ cells
were localized close to capillaries in human AT. However, the
authors did not provide immunohistochemical evidence
showing that perivascular CD34
þ cells are CD140b
þ. In this
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Figure 6 Influence of obesity on ASC cell number, adipogenic and
osteogenic gene expression. (a) Freshly harvested AT-SVF underwent
two-colour flow cytometry with fluorescent-labelled antibodies against
CD34 (PerCP) and CD31 (FITC). CD34
þ/CD31
  cell number (normalized
per gram of AT) was determined in lean (BMIo25kgm
 2, n¼50) class I obese
(BMI 30–34.9kgm
 2, n¼38) or class II–III obese (BMIX35kgm
 2, n¼59)
donors. (b) Mature adipocytes were isolated for mean diameter determination
in lean (n¼10), class I obese (n¼8) and class II–III obese (n¼18) donors.
(c) The mRNA expression of adipocyte markers GPDH and LPL (d) were
determined in freshly harvested ACSs cells by real-time RT-PCR. The results
were normalized to 18S rRNA levels and expressed as arbitrary units (AU).
Data are mean±s.e.m. from 4–8 independent experiments, *Po0.05, class I
versus classes II–III.
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are negative for CD140b and NG2 pericyte markers and that
cell culture induces the expression of both markers. There-
fore, although some CD140b
þ or NG2
þ cells were found in
the pericytic position in AT and some native ASCs could be
found close to capillaries, in situ native ASCs were invariably
negative for CD140b or NG2 markers. Our results agree with
those from a recent study involving immunohistology of the
AT endothelial network and showing that CD34 staining did
not co-localize with pericytic markers in human AT.
46,47 To
better define the stemness of ASCs, we investigated the
mRNA expression of Oct4 and Nanog genes. Indeed, the
molecular mechanisms governing ESC pluripotency have
provided insights into the role of transcription factors such
as Oct4 and Nanog in maintaining ESCs in the undifferen-
tiated state. Remarkably, these pluripotent factors have been
shown to participate in the reprogramming of differentiated
cells back to the pluripotent state.
48,49 Oct4 and Nanog genes
have been detected in various somatic tissue-derived cells,
the most often-cited cell type being BM-MSCs
50–53 and
culture-expanded ASCs. Although more poorly expressed in
ASCs than in ESCs, Oct4 and Nanog genes were found in
human native ASCs (a hallmark of pluripotency). However,
we cannot rule out that Oct4 retropseudogenes, unable to
compensate for loss of the original Oct4 gene, are actively
transcribed in both normal and transformed cells and could
contribute to false-positive signals.
54,55 Similar to Oct4 and
Nanog, the catalytic subunit of human telomerase (hTERT)
is described more as a stem cell marker for ESCs than for
adult stem/progenitor cells. Telomerase is expressed in
cultured ASCs.
56–59 We report for the first time that hTERT
is not detected in human native ASCs.
Finally, we studied the effects of AT microenvironment
changes on ASC adipogenic or osteogenic commitment.
Excessive AT development, as found in humans with obesity,
was associated with increased expression of adipogenic
differentiation genes and no change in expression of
osteogenic differentiation genes. The excessive development
of AT results from both hypertrophy of pre-existing adipo-
cytes and adipocyte hyperplasia due to the formation of new
adipocytes.
5,10 Because adipocytes are terminally differen-
tiated cells and therefore considered incapable of divi-
sion.
9,10 The apparent increase in adipocyte number is
thought to originate from adipogenesis and/or the prolifera-
tion or differentiation of adipocyte progenitor cells (pre-
adipocytes). We have recently demonstrated a correlation
between excessive AT development in humans and increased
number of mature adipocytes, together with increased
progenitor-cell proliferation.
60 Our current results indicate
that the number of native ASCs in subcutaneous AT was
lower in subjects with class II–III obesity who also exhibited
lower mean adipocyte diameter than class I obese donors.
Our unpublished observations indicate no association
between the number of ASCs and the duration of obesity.
Furthermore, the mRNA levels of adipogenic markers LPL
and GPDH were markedly higher in native ASCs from donors
with class II or III obesity than in those with class I obesity.
These findings suggest that ASCs may support the adipocyte
hyperplasia that occurs in severe obesity as shown by the
lower mean adipocyte diameter compared with class I obese
patients.
In conclusion, our use of complementary methodological
approaches to study native human ASCs from subcutaneous
AT revealed data regarding their immunophenotype, their
location within human AT, their 3-D morphology and their
stemness. Furthermore, our data strongly suggest that
human ASCs participate in adipogenesis, which occurs
during excessive AT development. Further studies are needed
to better understand how changes in AT microenvironment
could participate in ASC commitment and therefore help
elucidate the optimal conditions for developing viable and
safe tools for tissue engineering.
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